Interaction studies between human papillomavirus virus-like particles and laminin 332 by affinity capillary electrophoresis assisted by bio-layer interferometry.

Affinity capillary electrophoresis Bio-layer interferometry Dissociation constant Human papillomavirus Laminin 332 Virus-like particles

Journal

Talanta
ISSN: 1873-3573
Titre abrégé: Talanta
Pays: Netherlands
ID NLM: 2984816R

Informations de publication

Date de publication:
26 Dec 2023
Historique:
received: 29 09 2023
revised: 22 12 2023
accepted: 23 12 2023
medline: 11 1 2024
pubmed: 11 1 2024
entrez: 10 1 2024
Statut: aheadofprint

Résumé

Human papillomavirus (HPV) interacts, in vitro, with laminin 332 (LN332), a key component of the extracellular matrix. In this study, we performed bio-layer interferometry (BLI) and affinity capillary electrophoresis (ACE) to investigate the binding properties of this interaction. Virus-like particles (VLPs), composed of the HPV16 L1 major capsid protein, were used as HPV model and LN332 as the VLPs binding partner. Using BLI, we quantitatively determined the kinetics of the interaction, via the measurement of VLP binding and release from LN332 immobilized onto the surface of aminopropylsilane biosensors. We found an averaged k

Identifiants

pubmed: 38199121
pii: S0039-9140(23)01353-X
doi: 10.1016/j.talanta.2023.125602
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

125602

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Aurore Boclinville (A)

Laboratory for the Analysis of Medicines (LAM), Center for Interdisciplinary Research on Medicines (CIRM), University of Liège, Liège, Belgium.

Marylène Vandevenne (M)

InBioS - Centre for Protein Engineering, Département des Sciences de La Vie, University of Liège, Liège, Belgium.

Ernesto Ambroggio (E)

InBioS - Centre for Protein Engineering, Département des Sciences de La Vie, University of Liège, Liège, Belgium.

Nicolas Thelen (N)

Cellular and Tissular Biology, GIGA-Neurosciences, University of Liège, Liège, Belgium.

Marc Thiry (M)

Cellular and Tissular Biology, GIGA-Neurosciences, University of Liège, Liège, Belgium.

Nathalie Jacobs (N)

Cellular and Molecular Immunology, GIGA-Research, University of Liège, Liège, Belgium.

Alain Brans (A)

InBioS - Centre for Protein Engineering, Département des Sciences de La Vie, University of Liège, Liège, Belgium.

Marianne Fillet (M)

Laboratory for the Analysis of Medicines (LAM), Center for Interdisciplinary Research on Medicines (CIRM), University of Liège, Liège, Belgium.

Anne-Catherine Servais (AC)

Laboratory for the Analysis of Medicines (LAM), Center for Interdisciplinary Research on Medicines (CIRM), University of Liège, Liège, Belgium. Electronic address: acservais@uliege.be.

Classifications MeSH